PT283 – Greg McKee – Psychedelics for Nociplastic Pain episode artwork

EPISODE · Jan 31, 2022 · 1H 11M

PT283 – Greg McKee – Psychedelics for Nociplastic Pain

from Psychedelics Today

In this episode of the podcast, Joe interviews Greg McKee: Chairman and CEO of Tryp Therapeutics, an early-stage biotech company researching the use of psilocybin derivatives to alleviate nociplastic pain like fibromyalgia.   www.psychedelicstoday.com

Episode metadata supplied by the publisher feed · Published Jan 31, 2022

Embed this episode

NOW PLAYING

PT283 – Greg McKee – Psychedelics for Nociplastic Pain

0:00 1:11:34

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Psychedelics Today?

This episode is 1 hour and 11 minutes long.

When was this Psychedelics Today episode published?

This episode was published on January 31, 2022.

Can I download this Psychedelics Today episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!